Insider Stock Trading History of Valenzano Ken


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Valenzano Ken since year 2005. The trader's CIK number is 1492123. At the time of this reporting, Valenzano Ken is the SVP, Pharmacology & Biology of Amicus Therapeutics Inc . (stock ticker symbol FOLD). See this page for all insider trading activities at Amicus Therapeutics Inc .


Stock purchases, sales, and option exercises reported by insider Valenzano Ken since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2015-07-13 FOLD Amicus Therapeutics Inc Option Ex 15,000 15.00 225,000
2015-07-13 FOLD Amicus Therapeutics Inc Sale 15,000 15.00 225,000
2015-06-22 FOLD Amicus Therapeutics Inc Option Ex 20,500 13.85 284,007
2015-06-22 FOLD Amicus Therapeutics Inc Sale 20,500 13.85 284,007
2015-05-11 FOLD Amicus Therapeutics Inc Sale 13,000 10.85 140,998
2015-05-08 FOLD Amicus Therapeutics Inc Option Ex 25,000 .00 0
2015-04-15 FOLD Amicus Therapeutics Inc Option Ex 5,000 12.50 62,500
2015-04-15 FOLD Amicus Therapeutics Inc Sale 5,000 12.50 62,500
2015-03-20 FOLD Amicus Therapeutics Inc Option Ex 6,043 11.68 70,558
2015-03-20 FOLD Amicus Therapeutics Inc Sale 7,751 11.89 92,182
2015-03-20 FOLD Amicus Therapeutics Inc Option Ex 13,050 11.53 150,505
2015-03-20 FOLD Amicus Therapeutics Inc Sale 13,050 11.53 150,505
2014-11-25 FOLD Amicus Therapeutics Inc Buy 25,000 8.00 200,000
2014-11-25 FOLD Amicus Therapeutics Inc Sale 25,000 8.00 200,000
2014-08-25 FOLD Amicus Therapeutics Inc Sale 12,450 6.00 74,700
2014-08-25 FOLD Amicus Therapeutics Inc Buy 12,450 6.00 74,700
2014-08-20 FOLD Amicus Therapeutics Inc Buy 7,000 5.40 37,800
2014-08-20 FOLD Amicus Therapeutics Inc Sale 7,000 5.40 37,800
2011-05-24 FOLD Amicus Therapeutics Inc Option Ex 2,250 .64 1,435
2011-05-24 FOLD Amicus Therapeutics Inc Sale 2,250 7.50 16,875

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Valenzano Ken (SVP, Pharmacology & Biology of Amicus Therapeutics Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.